patent/WO-9639136-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9639136-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df27e7b654f03d376f9b6910e444f9f7
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate	1996-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3779c1f9ef10b97824212ad46106ccc2
publicationDate	1996-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-9639136-A1
titleOfInvention	Transdermal formulation comprising ropinirole
abstract	Transdermal formulations comprising ropinirole for use in treating Parkinson's Disease.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102361639-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021169849-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6884434-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871249-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010024717-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9849095-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580281-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2258355-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2716287-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2258355-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011291-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303986-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149834-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9918945-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9320728-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10251844-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009082268-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103561737-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238025-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8460706-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005240-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8882729-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10322093-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009112167-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19814084-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9155710-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19814084-B4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716763-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9186335-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005240-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2438917-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011132966-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2716287-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2438917-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7927624-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9155725-B2
priorityDate	1995-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0299602-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68727 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129370011 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5095 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421510 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467010773 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425929

Total number of triples: 59.